iBio IBIO Stock News

iBio Inc (NYSEAMERICAN: IBIO) is down again in the market this morning, adding to the declines that we’ve seen as of late. The stock has given up more than third of its value since late July, and unless management does something, it’s going to keep falling.

I’m calling out to you Mr. Isett. We need an update!

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

I Like IBIO Stock

Before we dig the hole too deep here, I want to be clear with my readers, I like IBIO stock. Sure, an investment here comes with its risks, but it also comes with its advantages.

Let’s not forget, iBio is currently working with a Chinese company that has experience in the development of vaccines for a sister version of the coronavirus to the one that causes COVID-19. They have two vaccine development programs, and they are the owners of the all-powerful FastPharming Facility.

There are tremendous benefits in all of these statements, learn more about them here.

Then There’s The Rub

We all know that the work that IBIO is doing is valuable. We know it’s not likely to be the first to bring a vaccine to market, but we understand the potential value of bringing it to market anyway. The revenue here could be tremendous, and the company’s technology could be further validated, setting a strong foundation for rocket-like growth.

We’ve believed in IBIO for some time now. The problem is that IBIO doesn’t seem to believe in us. We have seen very little communication with regard to the company’s work. The last press release on the matter came on June 24, 2020, when we learned that the company gained access to IBM Watson Health’s clinical trial tech.

That’s great news, but what have you done with it, Tom?

On June 4, 2020, we learned about a second COVID-19 vaccine program. Yet another feather in the hat, but what has happened since?

IBIO, we are nearly two full months from the last press release surrounding your work with regard to the development of a COVID-19 vaccine. A lot has changed in those two months. We’ve seen constant communication from other players in the space. Some vaccines are expected to become available later this year, although, there are plenty of questions surrounding them.

The question is, why haven’t we heard anything from you. Tom, Glenn, Seymour, give us something here guys. Your investors are losing faith.

Final Thoughts

I stand behind my belief that iBio presents a massive opportunity should all go well. I also stand behind the belief that when news does come out, it could trigger a short squeeze, eating away at the losses seen on the stock over the past few weeks.

Nonetheless, I’d love to see an update, and by what I’m seeing on message boards around the web, I’m not alone.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Don’t Miss The Next Big Story

Join our free mailing list below to receive real-time news alerts!

Subscribe Today!

* indicates required


2 COMMENTS

  1. Thank You!! I hope someone sends Tom Isett your article. You share the same opinion as many of us. This last week has been very discouraging.

  2. I think you are confusing investors with day traders who are losing faith. I can speak for plenty of longs that I have not sold a single share on the run up to $7 and have consistently been adding more seeing dips as buying opportunities. So you do not speak for investors like myself when you say we are losing faith, you speak for the penny flippers.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.